Product Information
PEGASYS 180 MCG/ML VIAL is a brand product labeled by pharmaand GmbH, priced at $1070.9040 per ML under NDC 82154044901. Its NADAC has been published 78 times since Oct 23, 2024.
Strength
180 ug/mL
Manufacturer
pharmaand GmbHNDC
82154044901
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
4/23/2025
Active Ingredients
PEGINTERFERON ALFA-2AApproval Type
Biologic (BLA)
FDA Application
BLA103964On Market Since
10/16/2002
Pharmacological Classes
Price Statistics
The NADAC for PEGASYS 180 MCG/ML VIAL has been published 78 times since Oct 23, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $1070.9040 per ML |
|---|---|
| All-time high | $1070.9040 (Apr 15, 2026) |
| All-time low | $1070.9040 (Oct 23, 2024) |
| 52-week high | $1070.9040 |
| 52-week low | $1070.9040 |
| Median price | $1070.9040 |
| Average price | $1070.9040 |
| Largest weekly change | 0.0% (Oct 30, 2024) |
| Weeks tracked | 78 |
| Tracking since | Oct 23, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
0.0%
1Y
0.0%
3Y
N/A
5Y
N/A
All
0.0%
Last surveyed Apr 15, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the peginterferon alfa-2a market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
pharmaand GmbH manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
peginterferon alfa-2a market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PEGASYS 180 MCG/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for PEGASYS 180 MCG/ML VIAL, manufactured by pharmaand GmbH, is $1070.9040 per ML (NDC 82154044901), effective Apr 15, 2026.
How has the price of PEGASYS 180 MCG/ML VIAL changed over time?
Over the history we have for it, the NADAC for PEGASYS 180 MCG/ML VIAL has held within roughly two percent of its current level. It has been tracked across 78 weekly CMS publications since Oct 23, 2024.
What are the highest and lowest recorded NADAC prices for PEGASYS 180 MCG/ML VIAL?
Since Oct 23, 2024, the NADAC for PEGASYS 180 MCG/ML VIAL has ranged from a low of $1070.9040 (Oct 23, 2024) to a high of $1070.9040 (Apr 15, 2026), with a median of $1070.9040 per ML.
Are there cheaper alternatives to PEGASYS 180 MCG/ML VIAL?
No other NADAC-published product currently shares the active ingredient and strength of PEGASYS 180 MCG/ML VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PEGASYS 180 MCG/ML VIAL?
PEGASYS 180 MCG/ML VIAL (NDC 82154044901) is labeled by pharmaand GmbH, and CMS classifies it as a brand product.